-
IN RE SUGAMMADEX DC CAFC
- 2:20-cv-02576
- D.N.J.
- Judge: Claire C. Cecchi
+1
- Filed: 03/10/2020
- Closed: 06/29/2023
- Latest Docket Entry: 08/09/2023
- PACER
2
Plaintiffs
32
Defendants
2
Accused
Products
1
Patent-in-Suit
1,207
Days in
Litigation
-
IN RE SUGAMMADEX DC CAFC
- 2:20-cv-02576
- D.N.J.
- Judge: Claire C. Cecchi
+1
- Filed: 03/10/2020
- Closed: 06/29/2023
- Latest Docket Entry: 08/09/2023
- PACER
Causes of Action
Infringement
Willful Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 4 |
A 6-mercapto-cyclodextrin derivative according to claim 1 selected from the group consisting of: 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ-cyclodextrin; 6-per-deoxy-6-per-(3-carboxypropyl)thio-γ-cyclodextrin;
view more
|
Valid
Entry 423 |
| 12 |
<?insert-start id="REI-00003" date="20140128" ?>12. 6-Per-deoxy-6-per-(2-carboxyethyl)thio-γ-cyclodextrin, sodium salt.<?insert-end id="REI-00003" ?>
|
Valid
Entry 423 |
| 21 |
<?insert-start id="REI-00012" date="20140128" ?>21. A method for reversal of drug-induced neuromuscular block in a subject, which comprises parenterally administering to said subject an effective amount of
view more
|
Valid
Entry 423 |
-
Infringement
Aurobindo Pharma Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Aurobindo Pharma USA Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Dr. Reddy's Lab., Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Dr. Reddy's Laboratories Ltd.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Eugia Pharma Specialties Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Fresenius KABI USA LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Gland Pharma Ltd.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Lek Pharmaceuticals, d.d.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Lifestar Pharma LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Mankind Pharma Ltd.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Mylan API US LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Mylan Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Sandoz Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Sun Pharmaceutical Industries, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
Teva Pharmaceuticals USA, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
USV Private Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic versions of sugammadex 200 mg/2 mL injectiongeneric versions of sugammadex 500 mg/5 mL injection | US RE44,733 E1 |
4, 12, 21
|
Infringement
Entry 423
|
